Management of Recurrent Pharyngitis

Initial Diagnostic Approach

The American Academy of Pediatrics and the Infectious Diseases Society of America recommend determining whether patients with recurrent pharyngitis and positive GAS testing represent true recurrent infections versus chronic GAS carriage with intercurrent viral infections, as chronic carriers do not require antibiotic treatment and are at minimal risk for complications 1, 2
Patients with recurrent pharyngitis can be categorized into three primary scenarios: multiple true GAS infections, chronic GAS carriage, and treatment failure, each with distinct characteristics and management strategies 1, 2
Chronic GAS carriers can be identified by positive throat cultures or RADT without rising anti-streptococcal antibody titers, colonization persisting for 6 months or more, and clinical features suggesting a viral etiology, with minimal risk for rheumatic fever or spreading infection to contacts 1, 2

For patients with true recurrent GAS pharyngitis, first-line alternative regimens include clindamycin, amoxicillin-clavulanate, intramuscular benzathine penicillin G, and penicillin with rifampin, which are more effective than repeat penicillin courses in eradicating GAS from carriers 3, 4, 5
The American Heart Association recommends penicillin with rifampin for patients with recurrent GAS pharyngitis, as it provides better eradication of GAS from carriers 5

Tonsillectomy is not recommended solely to reduce the frequency of GAS pharyngitis, but may be considered for patients with frequent recurrent episodes, no alternative explanation for recurrent pharyngitis, and multiple documented episodes despite appropriate antibiotic therapy 1, 2, 4
The American Academy of Otolaryngology recommends tonsillectomy for patients with recurrent pharyngitis who meet specific criteria, including frequent episodes and lack of response to antibiotic therapy 4

The American Academy of Pediatrics recommends symptomatic relief for all patients with pharyngitis, including NSAIDs, topical anesthetics, and warm salt water gargles, while avoiding aspirin in children and corticosteroids due to minimal benefit and potential adverse effects 1, 2, 3

The American Heart Association recommends continuous antimicrobial prophylaxis for patients with prior rheumatic fever, with duration of prophylaxis depending on the presence of carditis and residual heart disease, to prevent recurrent attacks and worsening cardiac disease 5
The recommended duration of secondary prophylaxis is 10 years or until age 40 for patients with rheumatic fever and carditis, and 5 years or until age 21 for patients without carditis 5

The Infectious Diseases Society of America recommends avoiding routine retesting after treatment, treating asymptomatic household contacts, confusing chronic carriers with active infection, using short courses of standard antibiotics, and assuming all positive tests represent active infection in patients with recurrent episodes 1, 2, 3, 6, 7